Core Viewpoint - The company Jiangyin Beirisen Biochemical Technology Co., Ltd. is leading the development of mussel adhesive protein for medical applications, having recently completed a new round of equity financing to accelerate clinical development of its products [1] Group 1: Original Research Breakthroughs - Mussel adhesive protein, extracted from mussels, is recognized for its anti-inflammatory and immune barrier reconstruction properties, earning it the title of "marine soft gold" [3] - Beirisen is the first company globally to apply mussel adhesive protein in the medical field, establishing a full industry chain from laboratory research to market commercialization since its founding in January 2011 [5] Group 2: New Medical Aesthetic Injection Market - Beirisen has overcome three major global challenges in the production of mussel adhesive protein: purification difficulty, high costs, and storage at room temperature [7] - The company has successfully purified mussel adhesive protein to over 70% medical-grade standards and achieved a three-year room temperature storage capability [7] - Beirisen has filed over 100 patents covering the entire process from raw material preparation to clinical application, with its Class III medical device for intradermal injection showing significant efficacy in anti-inflammatory repair and wound healing [7] Group 3: Capital and Industry Dual-Drive - The recent financing will focus on three main areas: accelerating clinical transformation of multiple product lines, building a closed-loop full industry chain, and deepening international research cooperation [11] - Beirisen aims to establish its own GMP-standard production workshop and cold chain logistics system to control the entire process from raw material preparation to end products [11] - The company is transitioning from a regional innovative enterprise to a globally competitive original manufacturer of biomaterials, expanding the application of mussel adhesive protein from single applications to multi-scenario medical solutions [11]